These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 35915143)

  • 21. Identification of novel cytogenetic markers with prognostic significance in a series of 968 patients with primary myelodysplastic syndromes.
    Solé F; Luño E; Sanzo C; Espinet B; Sanz GF; Cervera J; Calasanz MJ; Cigudosa JC; Millà F; Ribera JM; Bureo E; Marquez ML; Arranz E; Florensa L
    Haematologica; 2005 Sep; 90(9):1168-78. PubMed ID: 16154839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical prognostic factors for survival and risk of progression to acute myeloid leukemia in patients with myelodysplastic syndromes with < 10% marrow blasts and non-unfavorable cytogenetic categories.
    Falantes JF; Calderón C; Márquez Malaver FJ; Alonso D; Martín Noya A; Carrillo E; Martino ML; Montero I; González J; Parody R; Espigado I; Pérez-Simón JA
    Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):144-52. PubMed ID: 23137720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optical Genome Mapping in Routine Cytogenetic Diagnosis of Acute Leukemia.
    Soler G; Ouedraogo ZG; Goumy C; Lebecque B; Aspas Requena G; Ravinet A; Kanold J; Véronèse L; Tchirkov A
    Cancers (Basel); 2023 Apr; 15(7):. PubMed ID: 37046792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Feasibility of Optical Genome Mapping in Cytogenetic Diagnostics of Hematological Neoplasms: A New Way to Look at DNA.
    Coccaro N; Anelli L; Zagaria A; Tarantini F; Cumbo C; Tota G; Minervini CF; Minervini A; Conserva MR; Redavid I; Parciante E; Macchia MG; Specchia G; Musto P; Albano F
    Diagnostics (Basel); 2023 May; 13(11):. PubMed ID: 37296693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optical Genome Mapping as a New Tool to Overcome Conventional Cytogenetics Limitations in Patients with Bone Marrow Failure.
    Iriondo J; Gómez A; Zubicaray J; Garcia-Martinez J; Abad L; Matesanz C; Giménez R; Galán A; Sanz A; Sebastián E; González de Pablo J; de la Cruz A; Ramírez M; Sevilla J
    Genes (Basel); 2024 Apr; 15(5):. PubMed ID: 38790188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Biologic and clinical relevance of cytogenetic analysis in primary myelodysplastic syndromes].
    Raynaud SD
    Pathol Biol (Paris); 2003 Aug; 51(6):346-55. PubMed ID: 12927892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analytic Validation of Optical Genome Mapping in Hematological Malignancies.
    Pang AWC; Kosco K; Sahajpal NS; Sridhar A; Hauenstein J; Clifford B; Estabrook J; Chitsazan AD; Sahoo T; Iqbal A; Kolhe R; Raca G; Hastie AR; Chaubey A
    Biomedicines; 2023 Dec; 11(12):. PubMed ID: 38137484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prognostic potential of morphological and cytogenetic indices in patients with myelodysplastic syndrome].
    Gritsaev SV; Martynkevich IS; Abdulkadyrov KM; Tiranova SA; Kakaĭ MP; Martynenko LS; Dziavgo LA
    Ter Arkh; 2005; 77(7):22-7. PubMed ID: 16116904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optical Genome Mapping for Comprehensive Cytogenetic Analysis of Soft-Tissue and Bone Tumors for Diagnostic Purposes.
    Baelen J; Dewaele B; Debiec-Rychter M; Sciot R; Schöffski P; Hompes D; Sinnaeve F; Wafa H; Vanden Bempt I
    J Mol Diagn; 2024 May; 26(5):374-386. PubMed ID: 38395407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical significance of cytogenetic and molecular genetic abnormalities in 634 Chinese patients with myelodysplastic syndromes.
    Yan X; Wang L; Jiang L; Luo Y; Lin P; Yang W; Ren Y; Ma L; Zhou X; Mei C; Ye L; Xu G; Xu W; Yang H; Lu C; Jin J; Tong H
    Cancer Med; 2021 Mar; 10(5):1759-1771. PubMed ID: 33609081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of optical genome mapping for detecting chromosomal translocation in clinical cytogenetics.
    Dai P; Zhu X; Pei Y; Chen P; Li J; Gao Z; Liang Y; Kong X
    Mol Genet Genomic Med; 2022 Jun; 10(6):e1936. PubMed ID: 35384386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optical genome mapping, a promising alternative to gold standard cytogenetic approaches in a series of acute lymphoblastic leukemias.
    Lestringant V; Duployez N; Penther D; Luquet I; Derrieux C; Lutun A; Preudhomme C; West M; Ouled-Haddou H; Devoldere C; Marolleau JP; Garçon L; Jedraszak G; Ferret Y
    Genes Chromosomes Cancer; 2021 Oct; 60(10):657-667. PubMed ID: 33982372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of deleted chromosome 5 in complex chromosomal aberrations in newly diagnosed myelodysplastic syndromes (MDS) is correlated with extremely adverse prognosis.
    Zemanova Z; Michalova K; Buryova H; Brezinova J; Kostylkova K; Bystricka D; Novakova M; Sarova I; Izakova S; Lizcova L; Ransdorfova S; Krejcik Z; Merkerova MD; Dohnalova A; Siskova M; Jonasova A; Neuwirtova R; Cermak J
    Leuk Res; 2014 May; 38(5):537-44. PubMed ID: 24636338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The myelodysplastic syndromes: analysis of prognostic factors and comparison of prognostic systems in 128 Chinese patients from a single institution.
    Zhao WL; Xu L; Wu W; Yan H; Tang W; Hu J; Chen Y; Li JM; Zeng XY; Xiong SM; Shen ZX; Chen Z; Wang ZY; Chen SJ
    Hematol J; 2002; 3(3):137-44. PubMed ID: 12111649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optical Genome Mapping Reveals and Characterizes Recurrent Aberrations and New Fusion Genes in Adult ALL.
    Vieler LM; Nilius-Eliliwi V; Schroers R; Vangala DB; Nguyen HP; Gerding WM
    Genes (Basel); 2023 Mar; 14(3):. PubMed ID: 36980958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Prognostic Factors in 86 Chinese Patients with Primary Myelodysplastic Syndromes and Trisomy 8: A Single Institution Experience.
    Yue QF; Chen L; She XM; Hu B; Hu Y; Zou P; Liu XY
    Yonsei Med J; 2016 Mar; 57(2):358-64. PubMed ID: 26847287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical outcomes and characteristics of patients with
    Zhang L; Chen K; Li Y; Chen Q; Shi W; Ji T; Tao H; He Z; Wang C; Yu L
    Hematology; 2023 Dec; 28(1):2181773. PubMed ID: 36892252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic and prognostic significance of cytogenetics in adult primary myelodysplastic syndromes.
    Jotterand M; Parlier V
    Leuk Lymphoma; 1996 Oct; 23(3-4):253-66. PubMed ID: 9031106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of complex and cryptic chromosomal rearrangements by optical genome mapping.
    Shi S; Huang P; Yan R; Li R
    Mol Cytogenet; 2023 Apr; 16(1):5. PubMed ID: 37101225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Validation and Diagnostic Utility of Optical Genome Mapping in Prenatal Diagnostic Testing.
    Sahajpal NS; Mondal AK; Fee T; Hilton B; Layman L; Hastie AR; Chaubey A; DuPont BR; Kolhe R
    J Mol Diagn; 2023 Apr; 25(4):234-246. PubMed ID: 36758723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.